Edition:
India

EyePoint Pharmaceuticals Inc (EYPT.OQ)

EYPT.OQ on NASDAQ Stock Exchange Global Market

1.73USD
1:30am IST
Change (% chg)

$-0.02 (-1.14%)
Prev Close
$1.75
Open
$1.75
Day's High
$1.76
Day's Low
$1.70
Volume
99,402
Avg. Vol
54,686
52-wk High
$2.45
52-wk Low
$0.93

Chart for

About

Eyepoint Pharmaceuticals, Inc., formerly pSivida Corp, develops drug delivery products primarily for the treatment of chronic eye diseases. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 39.32
Dividend: --
Yield (%): --

Financials

BRIEF-Eyepoint Pharmaceuticals U.S. Patent And Trademark Office Has Issued Notices Of Allowance For Two Patents Covering DEXYCU

* U.S. PATENT AND TRADEMARK OFFICE HAS ISSUED NOTICES OF ALLOWANCE FOR TWO PATENTS COVERING DEXYCU Source text for Eikon: Further company coverage:

12 Apr 2018

Earnings vs. Estimates